Leerink Swann Downgrades Pharmacyclics (PCYC) to Market Perform
Tweet Send to a Friend
Leerink Swann downgraded Pharmacyclics (NASDAQ: PCYC) from Outperform to Market Perform with a price target of $97.00 (from $80.00) on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
